Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Edan

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 12, 2012
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosisIris-Katharina Penner, Brigitte Stemper, Pasquale Calabrese, et al.
Annals of Clinical and Translational Neurology|October 7, 2014
Molecular mechanism underlying the impact of vitamin D on disease activity of MSKassandra L Munger, Karl Köchert, Kelly C Simon, et al.
JAMIA Open|May 14, 2026
PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosisStanislas Demuth, Igor Faddeenkov, Julien Paris, et al.
Trials|July 1, 2020
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trialKatline Metzger-Peter, Laurent Daniel Kremer, Gilles Edan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 3, 2016
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled studyAyman Tourbah, Christine Lebrun-Frenay, Gilles Edan, et al.
The New England Journal of Medicine|June 22, 2007
Natural history of multiple sclerosis with childhood onsetChristel Renoux, Sandra Vukusic, Yann Mikaeloff, et al.
Annals of Neurology|November 12, 2005
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"Chris H Polman, Stephen C Reingold, Gilles Edan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2013
Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndromeGijsbert J A Nagtegaal, Christoph Pohl, Mike P Wattjes, et al.
Plos One|July 7, 2015
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational StudyEmmanuelle Leray, Sandra Vukusic, Marc Debouverie, et al.
Annals of Neurology|June 5, 2003
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1aFrederik Barkhof, Mara Rocca, Gordon Francis, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 12, 2012
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosisIris-Katharina Penner, Brigitte Stemper, Pasquale Calabrese, et al.
Annals of Clinical and Translational Neurology|October 7, 2014
Molecular mechanism underlying the impact of vitamin D on disease activity of MSKassandra L Munger, Karl Köchert, Kelly C Simon, et al.
JAMIA Open|May 14, 2026
PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosisStanislas Demuth, Igor Faddeenkov, Julien Paris, et al.
Trials|July 1, 2020
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trialKatline Metzger-Peter, Laurent Daniel Kremer, Gilles Edan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 3, 2016
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled studyAyman Tourbah, Christine Lebrun-Frenay, Gilles Edan, et al.
The New England Journal of Medicine|June 22, 2007
Natural history of multiple sclerosis with childhood onsetChristel Renoux, Sandra Vukusic, Yann Mikaeloff, et al.
Annals of Neurology|November 12, 2005
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"Chris H Polman, Stephen C Reingold, Gilles Edan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2013
Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndromeGijsbert J A Nagtegaal, Christoph Pohl, Mike P Wattjes, et al.
Plos One|July 7, 2015
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational StudyEmmanuelle Leray, Sandra Vukusic, Marc Debouverie, et al.
Annals of Neurology|June 5, 2003
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1aFrederik Barkhof, Mara Rocca, Gordon Francis, et al.
Pageof 15